Recombinant Bacillus subtilis Uncharacterized protein ymaG (ymaG)

Shipped with Ice Packs
In Stock

Description

Introduction to YmaG

YmaG is a hypothetical protein encoded by the ymaG gene in Bacillus subtilis subsp. subtilis str. 168. Its precise biological role remains uncharacterized, but it is implicated in spore coat assembly and structural integrity . Recombinant YmaG is typically produced with a hexahistidine (His) tag for purification and detection .

Recombinant Expression Systems

Recombinant YmaG is produced in heterologous hosts such as E. coli or yeast systems. Technical details include:

  • Expression Vector: Customizable constructs with N- or C-terminal His tags .

  • Yield: Requires 5–9 weeks for custom production .

  • Purity: >80% by SDS-PAGE analysis .

  • Endotoxin Levels: <1.0 EU/μg .

A study by Scheidler et al. (see ) included YmaG in a spore display library, where it was successfully tagged with β-glucuronidase (GUS) at its native locus without disrupting sporulation.

Role in Spore Coat Assembly

  • YmaG localizes to the inner spore coat layer and colocalizes with synthetic markers like TMR-star, which binds inner coat substrates .

  • During sporulation, YmaG-GFP appears at the forespore midspore region 44 ±20 minutes after TMR-star detection and expands bidirectionally to encase the forespore within 135 ±35 minutes .

  • Genetic dependency studies suggest YmaG requires intact spore coat assembly machinery (e.g., cotE, spoVID) for proper localization .

Interactions

  • YmaG colocalizes with inner coat proteins LipC and YeeK during late sporulation stages .

  • It exhibits minimal interaction with outer coat proteins like CotY or SpsI .

Research Applications

  • Spore Display: YmaG has been used as a fusion carrier for displaying heterologous proteins (e.g., GUS) on B. subtilis spores .

  • Live-Cell Imaging: YmaG-GFP fusions enable real-time tracking of inner coat dynamics using lattice-SIM² microscopy .

  • Biotechnology: Potential applications include vaccine development, enzyme immobilization, and biosensing due to its surface-exposed localization .

Product Specs

Form
Lyophilized powder
Note: We prioritize shipping the format currently in stock. However, if you have a specific format requirement, please indicate it in your order notes, and we will prepare it accordingly.
Lead Time
Delivery time may vary depending on the purchasing method and location. Please consult your local distributors for specific delivery timelines.
Note: All our proteins are shipped with standard blue ice packs. If dry ice shipping is required, please inform us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial prior to opening to ensure the contents are at the bottom. Reconstitute the protein in deionized sterile water to a concentration between 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard final concentration of glycerol is 50%, which can serve as a reference for your usage.
Shelf Life
Shelf life is influenced by various factors, including storage conditions, buffer ingredients, storage temperature, and the intrinsic stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is necessary for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is decided during the production process. If you have a specific tag type preference, please inform us, and we will prioritize developing it for you.
Synonyms
ymaG; BSU17310; Uncharacterized protein YmaG
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-91
Protein Length
full length protein
Species
Bacillus subtilis (strain 168)
Target Names
ymaG
Target Protein Sequence
MNELEHFSPEDTRIFGRPFGFGRPFGFGRPFGFGYGFGRPGFGYGFGRPFGFFGGPFIGG LAGGLIGSALFNPYLYGGYPYYPYAPFPFYY
Uniprot No.

Target Background

Gene References Into Functions
  1. ymaG proteins are present in the inner spore coat of Bacillus subtilis. PMID: 19933362
Database Links
Subcellular Location
Cell membrane; Single-pass membrane protein.

Q&A

What is the current state of knowledge about uncharacterized proteins in Bacillus subtilis?

Uncharacterized proteins in Bacillus subtilis represent significant gaps in our understanding of this model organism's proteome. While many B. subtilis proteins have been functionally characterized, a substantial number remain annotated only by their gene designations (such as ymaG, yhgB, etc.) with limited or no functional data available . These proteins are typically identified through genome sequencing and computational prediction but lack experimental validation of their biological roles. Current research focuses on applying combinatorial approaches including transcriptomics, proteomics, and structural analysis to elucidate their functions within cellular pathways.

How does the expression system for recombinant Bacillus subtilis proteins differ from other bacterial expression systems?

B. subtilis offers several distinct advantages as an expression system compared to other bacterial platforms. Unlike gram-negative expression systems, B. subtilis is a non-pathogenic gram-positive bacterium that does not produce endotoxins, making it particularly suitable for protein production for biomedical applications . The B. subtilis expression system typically utilizes plasmids such as pHT43 with inducible promoters that allow controlled expression upon addition of inducers like IPTG . The WB800N strain is commonly employed as it lacks eight extracellular proteases, significantly improving recombinant protein yield and stability . Unlike E. coli systems, B. subtilis can efficiently secrete proteins into the culture medium, eliminating the need for cell disruption in many cases.

What bioinformatic approaches are most effective for initial characterization of uncharacterized proteins like ymaG?

The most effective bioinformatic approaches for initial characterization include:

  • Sequence homology analysis using BLAST and HMM-based tools to identify distant relatives

  • Structural prediction using AlphaFold2 or similar tools to generate 3D models

  • Protein domain and motif identification using InterPro, SMART, and Pfam databases

  • Phylogenetic analysis to establish evolutionary relationships

  • Gene neighborhood analysis to identify potential functional associations

These computational methods can provide initial hypotheses about protein function based on sequence conservation patterns, structural features, and genomic context. For uncharacterized B. subtilis proteins, comparative analysis with other Bacillus species and gram-positive bacteria can be particularly informative for generating testable hypotheses about potential functions.

What are the key challenges in purifying recombinant uncharacterized proteins from Bacillus subtilis?

Purifying uncharacterized proteins presents several methodological challenges:

  • Expression optimization: Without knowledge of the native expression conditions, determining optimal induction parameters requires systematic testing of temperatures, induction times, and inducer concentrations.

  • Solubility issues: Uncharacterized proteins may form inclusion bodies or aggregate, necessitating optimization of solubilization buffers.

  • Stability concerns: Some proteins may be intrinsically unstable or sensitive to proteolysis despite the use of protease-deficient strains.

  • Purification strategy development: Without knowledge of biochemical properties, developing an effective purification scheme requires empirical testing of different chromatography methods.

  • Functional validation: Confirming that the purified protein retains native functionality is difficult without established activity assays.

For B. subtilis specifically, the WB800N strain helps address proteolysis concerns, but researchers must still optimize expression conditions for each new target protein .

What evidence suggests potential functions for uncharacterized proteins in Bacillus subtilis?

Several lines of evidence can suggest potential functions:

  • Gene expression patterns during different growth phases or stress conditions

  • Phenotypic changes in knockout mutants

  • Protein-protein interaction studies

  • Subcellular localization patterns

  • Structural similarities to characterized proteins

For instance, with the uncharacterized protein yhgB in B. subtilis, researchers have used supplier resources to obtain recombinant forms for functional studies . Similarly, for the elongation factor P in B. subtilis, researchers identified its role in swarming motility by examining expression patterns in motile cells and identifying a specific post-translational modification (5-aminopentanol moiety attached to Lys32) required for function . These approaches provide templates for investigating other uncharacterized proteins like ymaG.

How can fluorescent reporter systems be optimized to study the expression patterns of uncharacterized proteins like ymaG?

Fluorescent reporter systems can be developed following similar approaches to those used in B. subtilis studies on other proteins. A methodological approach includes:

  • Construct design: Generate fusion constructs linking the ymaG gene to fluorescent proteins like RFP (similar to the RFP-COE fusion approach described for other B. subtilis proteins) .

  • Promoter selection: Use either the native ymaG promoter to study natural expression patterns or inducible promoters for controlled expression.

  • Integration strategy: Either integrate the reporter construct into the chromosome at the native locus or use multi-copy plasmids like pHT43 .

  • Validation of expression: Confirm expression using Western blot with appropriate antibodies.

  • Quantitative analysis: Establish fluorescence microscopy or flow cytometry protocols to quantify expression under different conditions.

This approach allows visualization of spatial and temporal expression patterns, providing insights into when and where the protein might function. For example, in studies of other B. subtilis proteins, researchers successfully used RFP fusions to track protein expression and localization in vivo .

What post-translational modifications should be investigated in uncharacterized B. subtilis proteins?

Based on findings from other B. subtilis proteins, researchers should investigate several potential post-translational modifications:

  • Lysine modifications: Studies of elongation factor P (EF-P) in B. subtilis revealed a critical 5-aminopentanol modification of Lys32 that is essential for its function in swarming motility . This represents a modification pathway distinct from those in gram-negative bacteria.

  • Phosphorylation: Common in signaling pathways and regulatory proteins.

  • Proteolytic processing: May activate or regulate protein function.

  • Glycosylation: Though less common in bacteria than eukaryotes, it does occur.

  • Disulfide bond formation: May be important for structural stability.

Investigation should employ mass spectrometry-based proteomics to identify modifications, followed by site-directed mutagenesis to determine their functional significance. The discovery that B. subtilis EF-P uses a previously uncharacterized post-translational modification pathway suggests that novel modifications may exist for other uncharacterized proteins like ymaG.

How can gene knockout and complementation studies be designed to elucidate the function of ymaG?

A comprehensive gene knockout and complementation approach should include:

  • Knockout strategy design:

    • Generate a clean deletion of ymaG using homologous recombination

    • Verify deletion by PCR and sequencing

    • Ensure no polar effects on neighboring genes

  • Phenotypic analysis:

    • Growth kinetics under various conditions (temperature, pH, nutrient limitation)

    • Stress responses (oxidative, osmotic, antibiotic)

    • Morphological changes (microscopy)

    • Motility assays (swarming, swimming)

    • Biofilm formation capacity

  • Complementation tests:

    • Reintroduce ymaG under inducible control

    • Include tagged versions for localization and pulldown studies

    • Test variants with site-directed mutations of conserved residues

  • Cross-species complementation:

    • Test if homologs from related Bacillus species can complement the deletion

This systematic approach can reveal conditions where ymaG is essential or beneficial, providing functional insights. Similar approaches revealed the importance of EF-P in B. subtilis swarming motility .

What protein-protein interaction methods are most suitable for identifying binding partners of uncharacterized B. subtilis proteins?

For B. subtilis uncharacterized proteins, a multi-method approach is recommended:

  • Affinity purification-mass spectrometry (AP-MS):

    • Express ymaG with affinity tags (His, FLAG, etc.)

    • Perform pulldowns under native conditions

    • Identify binding partners by mass spectrometry

    • Validate with reciprocal pulldowns

  • Bacterial two-hybrid systems:

    • Adapt bacterial two-hybrid systems for B. subtilis

    • Screen against genomic libraries

    • Validate interactions with direct protein binding assays

  • Cross-linking mass spectrometry:

    • Use chemical cross-linkers to capture transient interactions

    • Identify interaction sites at amino acid resolution

  • Co-localization studies:

    • Use fluorescent protein fusions to track potential co-localization

    • Employ super-resolution microscopy techniques

  • Proximity-dependent biotin labeling:

    • Adapt BioID or APEX2 systems for B. subtilis

    • Identify proteins in the vicinity of ymaG in living cells

These methods can be applied sequentially, starting with broader techniques like AP-MS before moving to more focused validation approaches. Similar strategies have been used to identify interaction partners for other B. subtilis proteins involved in specific cellular processes .

How can structural biology approaches be applied to uncharacterized proteins when crystallization is challenging?

When crystallization proves difficult, alternative structural biology approaches include:

A combination of these approaches, integrated with biochemical and functional data, can provide valuable structural insights even when high-resolution crystal structures are unavailable. For B. subtilis proteins, expression optimization using the WB800N strain may improve sample quality for structural studies .

How should researchers interpret discrepancies between bioinformatic predictions and experimental results for uncharacterized proteins?

When confronting discrepancies between bioinformatic predictions and experimental results for proteins like ymaG, researchers should:

  • Re-evaluate bioinformatic predictions:

    • Check if the sequence used was complete and accurate

    • Try alternative algorithms or more sensitive search methods

    • Consider whether limited homology data may have affected predictions

  • Review experimental approach:

    • Assess if experimental conditions might have altered protein behavior

    • Verify that assays are appropriate for detecting predicted functions

    • Consider if tags or expression systems affected protein folding or function

  • Explore alternative hypotheses:

    • Consider that the protein may have multiple functions

    • Investigate whether post-translational modifications alter function

    • Examine if protein interactions are context-dependent

  • Perform integrative analysis:

    • Combine multiple experimental approaches (genetics, biochemistry, structural)

    • Consider system-level effects rather than isolated functions

    • Examine protein behavior under different physiological conditions

  • Document negative results:

    • Systematically record conditions where predicted functions were not observed

    • These data may guide future researchers toward correct functional assignments

The case of B. subtilis EF-P provides an instructive example where experimental work revealed a post-translational modification mechanism distinct from bioinformatic predictions based on gram-negative bacterial systems .

What statistical approaches should be used when analyzing high-throughput data related to uncharacterized proteins?

When analyzing high-throughput data for uncharacterized proteins like ymaG, researchers should implement:

  • Proper experimental design:

    • Include biological and technical replicates (minimum n=3)

    • Plan appropriate controls (positive, negative, and process controls)

    • Consider power analysis to determine sample size requirements

  • Data normalization methods:

    • For transcriptomics: RMA, quantile normalization, or TMM

    • For proteomics: Global median normalization or NSAF

    • For interactomics: SAINT or CompPASS scoring

  • Differential analysis approaches:

    • Parametric tests (t-test, ANOVA) when assumptions are met

    • Non-parametric alternatives when data violate normality assumptions

    • Correction for multiple hypothesis testing (Benjamini-Hochberg FDR)

  • Functional enrichment analysis:

    • Gene Ontology (GO) enrichment

    • Pathway analysis (KEGG, BioCyc)

    • Protein domain enrichment

  • Network-based approaches:

    • Protein interaction network analysis

    • Co-expression network construction

    • Integration of multi-omics data

Statistical rigor is particularly important when studying uncharacterized proteins to avoid over-interpretation of preliminary results. Similar approaches have been used in studies of B. subtilis proteins to identify peptide motifs dependent on post-translational modifications .

How can researchers distinguish between direct and indirect effects in phenotypic studies of ymaG knockout strains?

To distinguish between direct and indirect effects in ymaG knockout studies, researchers should:

  • Perform complementation analyses:

    • Reintroduce wild-type ymaG to confirm phenotype reversal

    • Use point mutants to identify critical functional residues

    • Test expression timing and levels to match native conditions

  • Conduct epistasis experiments:

    • Create double knockouts with genes in suspected pathways

    • Analyze whether phenotypes are additive, synergistic, or suppressive

    • Use overexpression of related genes to test for rescue effects

  • Employ time-resolved approaches:

    • Monitor sequential cellular events following gene deletion

    • Identify primary responses versus secondary adaptations

    • Use inducible knockout systems to observe immediate effects

  • Analyze molecular changes systematically:

    • Conduct transcriptomics and proteomics at multiple time points

    • Identify direct targets versus broader downstream changes

    • Look for consistent patterns across different experimental conditions

  • Use proximity-based methods:

    • Identify proteins and DNA directly interacting with ymaG

    • Map the physical interaction network surrounding the protein

This methodical approach helps establish causality rather than mere correlation. Studies of other B. subtilis proteins have successfully used reporter systems and genetic approaches to distinguish direct functional roles from secondary effects .

What approaches should be used to integrate transcriptomic, proteomic, and phenotypic data for uncharacterized protein function discovery?

For comprehensive functional discovery of uncharacterized proteins like ymaG, researchers should integrate multi-omics data through:

  • Multi-layer data collection:

    • Generate matched transcriptomic, proteomic, and phenotypic datasets

    • Include temporal dynamics when possible

    • Examine multiple conditions relevant to B. subtilis physiology

  • Correlation analysis:

    • Identify genes/proteins with similar expression patterns

    • Construct co-expression networks

    • Calculate correlation coefficients between omics layers

  • Pathway and network enrichment:

    • Map data onto known B. subtilis pathways

    • Identify enriched functional categories across datasets

    • Construct integrated networks spanning multiple data types

  • Machine learning approaches:

    • Use supervised learning to predict functions from integrated features

    • Apply unsupervised clustering to identify functional modules

    • Implement network propagation algorithms to extend functional annotations

  • Visualization and interaction tools:

    • Develop integrated visualizations of multi-omics data

    • Enable interactive exploration of functional relationships

    • Create databases to store and query integrated results

This integrative approach has proven successful in studies of other B. subtilis proteins, where combining genomic analysis with fluorescent reporter systems revealed functional roles in specific processes like swarming motility .

How should researchers validate hypotheses about uncharacterized protein function derived from high-throughput screening?

Validation of high-throughput screening results for uncharacterized proteins requires:

  • Orthogonal verification approaches:

    • Confirm interactions or phenotypes using different methodologies

    • Test in different strains or growth conditions

    • Use purified components in vitro when possible

  • Dose-response relationships:

    • Test effects at various protein expression levels

    • Create titration series for ligands or interacting molecules

    • Establish quantitative relationships supporting functional hypotheses

  • Structure-function analyses:

    • Generate mutants affecting predicted functional domains

    • Test activity or interactions with these variants

    • Correlate functional changes with structural features

  • In vivo relevance testing:

    • Determine if observed activities occur under physiological conditions

    • Test function during relevant B. subtilis physiological processes

    • Examine conservation of function across related Bacillus species

  • Mechanistic studies:

    • Establish biochemical mechanisms for observed functions

    • Define substrate specificity and catalytic parameters

    • Characterize regulatory mechanisms controlling protein activity

Similar approaches have been used to validate the role of post-translational modifications in B. subtilis proteins, where initial screening results were confirmed through detailed mechanistic studies .

How do uncharacterized proteins in Bacillus subtilis compare to homologs in other bacterial species?

Comparative analysis of uncharacterized proteins across bacterial species reveals:

  • Conservation patterns:

    • Core vs. accessory gene distribution

    • Phylogenetic distribution (restricted to Bacillus or broader)

    • Evolutionary rate compared to characterized proteins

  • Genomic context comparison:

    • Conservation of gene neighborhoods

    • Co-evolution with functionally related genes

    • Operon structure variations across species

  • Domain architecture analysis:

    • Presence of conserved domains vs. variable regions

    • Species-specific domain additions or deletions

    • Domain shuffling events during evolution

  • Functional divergence assessment:

    • Cases where homologs have known functions in other species

    • Evidence for neofunctionalization or subfunctionalization

    • Correlation with specific ecological niches or lifestyles

For example, studies of elongation factor P revealed that B. subtilis employs a post-translational modification pathway distinct from those in gram-negative bacteria, highlighting how even conserved proteins may have species-specific mechanisms .

What is the significance of studying uncharacterized proteins like ymaG for biotechnology applications of Bacillus subtilis?

Studying uncharacterized proteins has significant biotechnological implications:

  • Improved expression systems:

    • Understanding cellular machinery may enhance recombinant protein production

    • Identification of novel promoters, chaperones, or secretion mechanisms

    • Development of strains with optimized metabolism for bioproduction

  • Novel biocatalysts:

    • Discovery of enzymes with unique specificities or stabilities

    • Engineering of new catalytic functions based on structural insights

    • Development of whole-cell catalysts for industrial transformations

  • Vaccine development applications:

    • B. subtilis is increasingly used as a mucosal vaccine delivery system

    • Understanding surface proteins may improve antigen presentation

    • Knowledge of uncharacterized proteins may enhance immune responses

  • Synthetic biology tools:

    • Novel genetic parts for synthetic circuit design

    • Regulatory elements with unique properties

    • Orthogonal systems for controlled gene expression

The successful use of B. subtilis as a vaccine delivery system demonstrates how understanding previously uncharacterized components can enable new biotechnological applications .

How can structural similarities between uncharacterized proteins and characterized proteins guide functional hypothesis generation?

Structural similarities can inform function through several approaches:

  • Fold recognition and classification:

    • Identify proteins sharing the same fold despite low sequence similarity

    • Classify into known structural families with established functions

    • Recognize catalytic or binding site geometries

  • Active site comparison:

    • Identify conserved catalytic residues or binding pockets

    • Compare electrostatic surface properties

    • Analyze substrate binding channel architecture

  • Domain organization analysis:

    • Recognize functional domains in multi-domain proteins

    • Identify domain combinations predictive of specific functions

    • Compare domain orientation and interfaces

  • Molecular dynamics simulations:

    • Predict conformational changes relevant to function

    • Identify potential ligand binding sites

    • Simulate potential catalytic mechanisms

  • Structure-guided mutagenesis design:

    • Target residues predicted to be functionally important

    • Design mutations that should alter specific functions

    • Create chimeric proteins to test domain functions

This approach has been valuable for understanding other B. subtilis proteins, where structural features have informed functional hypotheses about uncharacterized proteins .

What experimental approaches can determine if uncharacterized proteins like ymaG are essential under specific environmental conditions?

To assess conditional essentiality of uncharacterized proteins, researchers should:

  • Develop conditional knockout systems:

    • Inducible gene deletion systems

    • Degradation tag approaches for protein depletion

    • Temperature-sensitive alleles

  • Perform comprehensive environmental screening:

    • Test growth across nutrient limitations

    • Examine responses to different stressors (pH, temperature, osmotic)

    • Analyze behavior during different growth phases

    • Assess competitive fitness in mixed cultures

  • Implement high-throughput phenotyping:

    • Automated growth curve analysis

    • Phenotype microarrays for metabolic profiling

    • Colony morphology screening

    • Microscopy-based morphological analysis

  • Conduct genetic interaction mapping:

    • Synthetic genetic array analysis

    • Transposon sequencing (Tn-seq) under different conditions

    • Suppressor screens to identify compensatory mutations

  • Monitor physiological parameters:

    • Measure metabolite levels

    • Analyze membrane potential

    • Assess cellular redox state

These approaches can reveal conditions where ymaG becomes critical for survival or competitive fitness, as demonstrated in studies of other B. subtilis proteins that showed condition-specific functions .

How can researchers contribute to community databases and resources for uncharacterized proteins in Bacillus subtilis?

Researchers can contribute to the scientific community's knowledge of uncharacterized proteins through:

  • Standardized data submission:

    • Deposit sequence data in GenBank/UniProt

    • Submit structures to Protein Data Bank

    • Share transcriptomic/proteomic data in appropriate repositories

    • Use consistent gene and protein nomenclature

  • Functional annotation contributions:

    • Update GO annotations with experimental evidence codes

    • Contribute to SubtiWiki or other B. subtilis-specific databases

    • Provide detailed methods in publications for reproducibility

  • Resource development:

    • Generate and share strain collections (knockouts, tagged proteins)

    • Develop and distribute plasmids for protein expression

    • Create and share antibodies or other research tools

  • Community engagement:

    • Participate in community annotation jamborees

    • Contribute to consensus functional predictions

    • Engage in collaborative projects on uncharacterized proteins

  • Negative results reporting:

    • Document unsuccessful approaches

    • Share conditions where predicted functions were not observed

    • Publish negative results to prevent duplication of effort

By systematically sharing both positive and negative results, researchers can accelerate the collective understanding of proteins like ymaG, similar to how knowledge about B. subtilis expression systems has been developed through community efforts .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.